2022-11-18
InvesTaiwan today (18th) approved the additional investments by 3 companies, including YFYCPG under the Action Plan for Welcoming Overseas Taiwanese Businesses to Return to Invest in Taiwan, and Yeong Jye Co., Ltd. and Primo Biotechnology Co., Ltd. under the Action Plan for Accelerated Investment by SMEs. At present, the three major programs for investing in Taiwan have attracted over NT$1.8226 trillion in investments from 1,279 companies, and are expected to create 140,758 domestic employment opportunities, in which the Action Plan for Welcoming Overseas Taiwanese Businesses to Return to Invest in Taiwan has attracted approximately NT$1,104.2 billion in investments from 276 Taiwanese businesses and created 84,385 domestic employment opportunities; the Action Plan for Accelerated Investment by SMEs has attracted approximately NT$385.5 billion in investments from 851 SMEs and created 32,438 domestic employment opportunities; the applications of 19 companies are still pending review.
YFYCPG’s mission is to “provide consumers with a healthy, safe, and wonderful life,” and supplies household paper and other cleaning products. Its products include “Mayflower,” “Delight,” and “Tender.” Its cleaning product brands include the number one brand of natural cleaning products “Orange House,” the fragrance focused “FreshSense,” and the affordable and effective “Delight.” Due to its emphasis on ESG, the company plans to invest over NT$1.9 billion to build a new plant in Qingshui, Taichung, install a solar PV system on the roof of its plant, and add a smart production line in its Taoyuan Yangmei Plant, in order to meet consumer demand on functional products. Its plants will strengthen waste management to ensure a sustainable production model, and convert reused materials and excess materials from processes into alternative fuel for boilers for the effective reuse of resources. It will also increase the number of times water is repeatedly used by building a papermaking circulation system. The investment is expected to create 61 domestic employment opportunities.
Yeong Jye Co., Ltd. produces sheet metal for wet process cleaning equipment, stainless steel working table, semiconductor machine frame, and basin cabinet. Following the development of the semiconductor industry driven by 5G, the market scale of the equipment industry has also increased, and the company’s current plants and equipment are no longer able to meet the demand from business growth. The company plans to recruit 26 domestic employees and increase investment by an additional over NT$150 million to add smart machinery and equipment in its new Renai Plant in Hsinchu City. The equipment and machinery comply with IE3 standards and reduce energy consumption. Furthermore, the plant will recycle metal solid waste and implement water conservation measures, enhancing its industrial strength with an eye on the global market, while deepening its roots in Taiwan for sustainability.
Primo Biotechnology Co., Ltd. is the first radiopharmaceuticals development company in Taiwan to originate from the medical field and academia, and has established a GMP certified pharmaceuticals plant that complies with the international standard PIC/S, while importing new pharmaceuticals together with international pharmaceuticals companies. Taiwan has had a long-term shortage of radiopharmaceuticals required for heart and cancer care. There are high technical barriers in manufacturing and transportation, so the global pharmaceuticals market has always been an emerging niche market. Primo Biotechnology thus plans to invest several hundred million NTD to build a plant with the highest specs, in order to build smart production lines and equipment that meet low carbon standards aligned with the trend of energy conservation and carbon reduction. Primo Biotechnology has strengthened its supply chain management. Besides complying with regulations on the transportation of radioactive materials, it is reducing unnecessary carbon emissions. While Primo Biotechnology dedicated its efforts to improving the quality of radiopharmaceuticals for nuclear medicine in Taiwan, it has adopted strict requirements for environmental protection and sustainability. After the first wave of investments is completed, it will increase employment opportunities and boost local prosperity.
Spokesperson of InvesTaiwan: Acting COO Chen Ming-Chu
Telephone: 02-2311-2031 Ext. 802
Mobile Phone: 0938-637-901
Email: nicole@invest.org.tw
Source： Department of Investment Services, MOEA
About Us
InvesTaiwan InvesTaiwan Service Center Department of Investment Promotion, MOEA Department of Investment Review, MOEA Contact TaiwanPlanning
Reasons to Invest Overview Key Industries for Investment Promotion Incentives Important Policies Success Stories
MOEA
MOEA DOIP
YouTube
Juiker App-Call Free
Let's Juiker Together
